Jun-Chao Guo

Dr. Jun-Chao Guo


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2016 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
XZXu Zhang
Xu Zhang
SHShuai Huang
Shuai Huang
JGJun-Chao Guo
Jun-Chao Guo
LZLi Zhou
Li Zhou
LYLei You
Lei You
YZYupei Zhao
Yupei Zhao
The biological processes of cancer cells such as tumorigenesis, proliferation, angiogenesis, apoptosis and invasion are greatly influenced by the surrounding microenvironment. The ability of solid malignant tumors to alter the microenvironment represents an important characteristic through which tumor cells are able to acquire specific functions necessary for their malignant biological behaviors. Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases with the capacity of remodeling extracellular matrix (ECM) by degrading almost all ECM proteins, which plays essential roles during the invasion and metastasis process of solid malignant tumors, including allowing tumor cells to modify the ECM components and release cytokines, ultimately facilitating protease-dependent tumor progression. MMP-11, also named stromelysin-3, is a member of the stromelysin subgroup belonging to MMPs superfamily, which has been detected in cancer cells, stromal cells and adjacent microenvironment. Differently, MMP-11 exerts a dual effect on tumors. On the one hand MMP-11 promotes cancer development by inhibiting apoptosis as well as enhancing migration and invasion of cancer cells, on the other hand MMP-11 plays a negative role against cancer development via suppressing metastasis in animal models. Overexpression of MMP-11 was discovered in sera of cancer patients compared with normal control group as well as in multiple tumor tissue specimens, such as gastric cancer, breast cancer, and pancreatic cancer. At present, some evidence supports that MMP-11 may work as a significant tumor biomarker for early detection of cancer, tumor staging, prognostic analysis, monitoring recurrence during follow-up and also a potential target for immunotherapy against cancer. In view of the importance of MMP-11 in modifying tumor microenvironment and potent antitumoral effects on solid tumors, there is an urgent need for a deeper understanding of how MMP-11 modulates tumor progression, and exploring its potential clinical application.

5 September 2015 in Pathology and Oncology Research
Verified
Journal Article
Closed access
PDF file
QSQian-Qian Shao
Qian-Qian Shao
TZTai-Ping Zhang
Tai-Ping Zhang
WZWen-Jing Zhao
Wen-Jing Zhao
Ziwen LiuZiwen Liu
Ziwen Liu
LYLei You
Lei You
YZYupei Zhao
Yupei Zhao

15 October 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
BJBolun Jiang
Bolun Jiang
LZLi Zhou
Li Zhou
JLJun Lu
Jun Lu
YWYizhi Wang
Yizhi Wang
CLChengxi Liu
Chengxi Liu
JGJun-Chao Guo
Jun-Chao Guo
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy with one of the worst prognoses worldwide and has an overall 5-year survival rate of only 9%. Although chemotherapy is the recommended treatment for patients with advanced PDAC, its efficacy is not satisfactory. The dense dysplastic stroma of PDAC is a major obstacle to the delivery of chemotherapy drugs and plays an important role in the progression of PDAC. Therefore, stroma-targeting therapy is considered a potential treatment strategy to improve the efficacy of chemotherapy and patient survival. While several preclinical studies have shown encouraging results, the anti-tumor potential of the PDAC stroma has also been revealed, and the extreme depletion might promote tumor progression and undermine patient survival. Therefore, achieving a balance between stromal abundance and depletion might be the further of stroma-targeting therapy. This review summarized the current progress of stroma-targeting therapy in PDAC and discussed the double-edged sword of its therapeutic effects.

1 June 2019 in Cancer Letters
Verified
Journal Article
Closed access
BLBing-Qi Li
Bing-Qi Li
ZLZhiyong Liang
Zhiyong Liang
SSSamuel Seery
Samuel Seery
QLQiaofei Liu
Qiaofei Liu
LYLei You
Lei You
YZYupei Zhao
Yupei Zhao

1 September 2020 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
YWYizhi Wang
Yizhi Wang
HWHongwei Wang
Hongwei Wang
LZLi Zhou
Li Zhou
JLJun Lu
Jun Lu
BJBolun Jiang
Bolun Jiang
JGJun-Chao Guo
Jun-Chao Guo

16 February 2018 in Oncology Letters
Verified
Journal Article
Closed access
PDF file
BPBoju Pan
Boju Pan
JGJun-Chao Guo
Jun-Chao Guo
QLQuan Liao
Quan Liao
YZYupei Zhao
Yupei Zhao
Integrins are transmembrane glycoproteins that consist of an α and a β subunit. Specific integrin heterodimers preferentially bind to distinct extracellular matrix (ECM) proteins to affect the characteristics of cells or the components of the ECM. Among the different integrins, β1 and β3 integrins serve essential roles in the progression of different cancer‑associated processes, including the initiation, proliferation, survival, migration and invasion. Furthermore, previous studies have revealed a ratio between these two integrins in cancer cells, which also demonstrated that the functions of these two integrins are paradoxical. This indicated that the proliferation and metastasis of cancer cells are not always parallel and may be considered independently maintained. Additionally, the present review may assist in understanding certain aspects of cancer, and in making clinical decisions in a novel and more comprehensive manner.